GENinCode (LON:GENI) Trading 9.5% Higher – Here’s What Happened

GENinCode Plc (LON:GENI) traded up 9.5% on Wednesday . The company traded as high as GBX 1.15 and last traded at GBX 1.15. 6,340,111 shares traded hands during mid-day trading, an increase of 9% from the average session volume of 5,811,077 shares. The stock had previously closed at GBX 1.05.

GENinCode Price Performance

The company has a debt-to-equity ratio of 7.17, a current ratio of 2.80 and a quick ratio of 15.89. The stock has a 50 day moving average price of GBX 1.13 and a two-hundred day moving average price of GBX 1.56. The firm has a market capitalization of £8.28 million, a price-to-earnings ratio of -0.49 and a beta of 0.61.

GENinCode Company Profile

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.